Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeffrey Afrifa-Yamoah
Institution:
Trinity Health Ann Arbor Hospital
Observed institutions:
Mater Dei Hospital,
Windsor University School of Medicine,
Korle Bu Teaching Hospital,
Trinity Health Ann Arbor Hospital
OpenAlex ID:
A5092475890
Heartache in a Bottle: Understanding Alcoholic Cardiomyopathy
2023
·
Nkechinyere L Ihekire
, Okelue E Okobi
, et al.
·
Cureus
·
16
PDF
Age Group Differences in the Awareness of Lifestyle Factors Impacting Cardiovascular Risk: A Population-Level Study
2023
·
Okelue E Okobi
, Ayomide H Adeyemi
, et al.
·
Cureus
·
11
PDF
965 Major adverse cardiovascular events following immune checkpoint blockade in metastatic prostate cancer: a large propensity-matched real-world analysis
2026
·
Nnamdi J Omenuko
, Chike Onyali
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
372 Comparative survival and immune-related adverse event profiles of PD-1 inhibition versus CTLA-4 blockade in malignant melanoma: a large-scale propensity score–matched real-world cohort study
2026
·
Damilola Ologbe
, Jeffrey Afrifa-Yamoah
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
407 Racial disparities in second primary hematologic malignancy risk during the chronological immunotherapy era among renal cell carcinoma survivors: a SEER population-based analysis
2026
·
Jeffrey Afrifa-Yamoah
, Michael Asare
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
408 Second primary malignancy risk across treatment eras in head and neck squamous cell carcinoma survivors: a SEER population-based analysis
2026
·
Jeffrey Afrifa-Yamoah
, Michael Asare
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
359 One-year neurologic and survival outcomes following CAR–T–associated immune effector cell–associated neurotoxicity syndrome in B-cell lymphoma: a propensity-matched real-world study
2026
·
Nnamdi J Omenuko
, Sara J Ozumba
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
613 Survival trends and clinical outcomes in multiple myeloma following BCMA-directed immunotherapy: a propensity score–matched real-world comparison of CAR-T cell therapy versus teclistamab
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
454 Second primary hematologic malignancies in melanoma survivors before and after the introduction of immune checkpoint inhibitors: a population-based SEER analysis
2026
·
Jeffrey Afrifa-Yamoah
, Duresha Malik
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
455 Second primary malignancy risk in the immunotherapy era among urothelial carcinoma survivors: a SEER population-based analysis
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
POSTER: MM-816: Racial Differences in Risk and Latency of Secondary Hematologic Malignancies Following Multiple Myeloma
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: HL-1463: Second Primary Malignancy Risk Among Survivors of Classical Hodgkin Lymphoma in the Pre- and Post-PD-1 Inhibitor Eras
2026
·
Olanipekun Lanny Ntukidem
, Oladayo Oyebanji
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-860: Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis
2026
·
Nnamdi Omenuko
, Deydie Suarez Salazar
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1446: Second Primary Malignancies in Multiple Myeloma: A Retrospective Population-Based Analysis
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MDS-854: Racial and Ethnic Disparities in Acute Myeloid Leukemia Transformation After Myelodysplastic Syndrome: A Population-Based Analysis of Incidence and Latency
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MDS-1422: Updated Incidence Trends in Myelodysplastic Syndrome: An Analysis of the SEER Database
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-841: Transformation of Multiple Myeloma Survival in the Novel Therapy Era: From a Once Rapidly Fatal Disease to a Chronic Malignancy
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
IBCL-665: Racial Disparities in Incidence of Non-Hodgkin Lymphoma as a Second Primary Malignancy Following Prostate Cancer: A Population-Based Study
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: TCL-1477: Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
TCL-1477: Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MDS-1422: Updated Incidence Trends in Myelodysplastic Syndrome: An Analysis of the SEER Database
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MDS-854: Racial and Ethnic Disparities in Acute Myeloid Leukemia Transformation After Myelodysplastic Syndrome: A Population-Based Analysis of Incidence and Latency
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: IBCL-665: Racial Disparities in Incidence of Non-Hodgkin Lymphoma as a Second Primary Malignancy Following Prostate Cancer: A Population-Based Study
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-816: Racial Differences in Risk and Latency of Secondary Hematologic Malignancies Following Multiple Myeloma
2026
·
Damilola Ologbe
, Olanipekun Lanny Ntukidem
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-1513: Second Primary Malignancies in Plasma Cell Leukemia: A Retrospective Population-Based Analysis
2026
·
Jeffrey Afrifa-Yamoah
, Damilola Ologbe
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
36
Citation count:
27
H-index:
2
I10-index:
2
Year
Topic
Type